Beranda › Migrain › Massachusetts
Uji klinis Migrain di Massachusetts
8 studi untuk Migrain mencari peserta di lokasi di Massachusetts.
Kota di Massachusetts
Teks studi resmi (Bahasa Inggris)
Study of EVO756 in Adults With Migraine
- Neurology Center of New England P.C., Foxborough
- Mass Institute of Clinical Research, Westborough
Menerima pesertaFase 2
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 2 Okt 2026 · NCT07616128Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Clinical Trials of New England, Hyde Park
Menerima pesertaFase 4
Usia 18 hingga 70 · Semua jenis kelamin · Diperbarui 16 Sep 2026 · NCT06972056A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine
- Boston Clinical Trials - Alcanza, Boston
- MedVadis Research Corporation, LLC, Waltham
Menerima pesertaFase 3
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 20 Agu 2026 · NCT07645924Cocoa Extract for Migraine Trial
- Brigham and Women's Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Jun 2026 · NCT06808230Chiropractic Care for Episodic Migraine
- Osher Center for Integrative Health, Mass General Brigham, Boston
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 26 Jun 2026 · NCT06229834BE WELL With Migraine: Brain Education and WELLness With Migraine
- Cambridge Health Alliance - Center for Mindfulness and Compassion, Cambridge
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 12 Jun 2026 · NCT05987592Mind Body Intervention for Chronic Migraine Headaches
- Beth Israel Deaconess Medical Center, Boston
- Beth Israel Deaconess Medical Center, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Mar 2026 · NCT06690060Acceptance and Commitment Therapy to Improve Disability in Chronic Migraine
- Brigham and Women's / Faulkner Hospital, Boston
Menerima peserta
Usia 18 hingga 65 · Semua jenis kelamin · Diperbarui 31 Okt 2025 · NCT06795867Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.